{
    "organizations": [],
    "uuid": "4ba394a5c6184f24de90d2fe43196fe014c02937",
    "author": "",
    "url": "https://www.reuters.com/article/brief-abarca-amgen-enter-outcomes-based/brief-abarca-amgen-enter-outcomes-based-agreement-for-repatha-idUSFWN1QC18U",
    "ord_in_thread": 0,
    "title": "BRIEF-Abarca, Amgen Enter Outcomes-Based Agreement For Repatha",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 33 PM / Updated 28 minutes ago BRIEF-Abarca, Amgen Enter Outcomes-Based Agreement For Repatha Reuters Staff 1 Min Read Feb 22 (Reuters) - Amgen Inc: * ‍ABARCA SAYS SIGNED OUTCOMES-BASED CONTRACT WITH AMGEN FOR CHOLESTEROL-LOWERING DRUG, REPATHA​ Source text for Eikon: Further company coverage:",
    "published": "2018-02-22T19:32:00.000+02:00",
    "crawled": "2018-02-22T19:51:27.023+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "amgen",
        "enter",
        "agreement",
        "repatha",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "amgen",
        "inc",
        "say",
        "signed",
        "contract",
        "amgen",
        "drug",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}